KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV)
CUSIP: 483497103
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 50,580,036
- Total 13F shares
- 54,890,685
- Share change
- -226,846
- Total reported value
- $633,782,153
- Put/Call ratio
- 0.51%
- Price per share
- $11.54
- Number of holders
- 127
- Value change
- +$5,364,849
- Number of buys
- 66
- Number of sells
- 58
Quarterly Holders Quick Answers
What is CUSIP 483497103?
CUSIP 483497103 identifies KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 483497103:
Top shareholders of KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13D/G
13F
|
Company |
9.9%
|
4,941,798
|
$63,650,358 | $0 | 31 Mar 2025 | |
| VR Adviser, LLC |
13F
|
Company |
12%
|
6,249,731
|
$52,935,222 | — | 31 Dec 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
9.7%
|
4,913,012
|
$41,613,212 | — | 31 Dec 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
9.7%
|
4,887,867
|
$41,400,233 | — | 31 Dec 2024 | |
| Capital World Investors |
13D/G
13F
|
Company |
6.4%
|
3,177,587
|
$40,927,321 | $0 | 31 Mar 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
9.4%
|
4,770,000
|
$40,401,900 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
5.7%
|
2,863,996
|
$24,258,047 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.5%
|
2,255,243
|
$19,101,908 | — | 31 Dec 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
3.5%
|
1,787,003
|
$15,135,915 | — | 31 Dec 2024 | |
| Boxer Capital Management, LLC |
13F
|
Company |
3.1%
|
1,590,000
|
$13,467,300 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.7%
|
1,390,863
|
$11,780,610 | — | 31 Dec 2024 | |
| Octagon Capital Advisors LP |
13F
|
Company |
2.7%
|
1,370,000
|
$11,603,900 | — | 31 Dec 2024 | |
| Woodline Partners LP |
13F
|
Company |
2.5%
|
1,288,401
|
$10,912,756 | — | 31 Dec 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
2%
|
992,803
|
$8,409,041 | — | 31 Dec 2024 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
1.7%
|
836,050
|
$7,081,344 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
822,352
|
$6,966,551 | — | 31 Dec 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
1.6%
|
811,678
|
$6,874,913 | — | 31 Dec 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
1.6%
|
805,445
|
$6,757,684 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.4%
|
696,037
|
$5,895,344 | — | 31 Dec 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
612,173
|
$5,185,105 | — | 31 Dec 2024 | |
| Saturn V Capital Management LP |
13F
|
Company |
1.1%
|
556,489
|
$4,713,462 | — | 31 Dec 2024 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
1.1%
|
549,688
|
$4,655,857 | — | 31 Dec 2024 | |
| Thomas Andrew Crockett |
3/4/5
|
CEO, Director |
—
mixed-class rows
|
322,315
mixed-class rows
|
$4,648,801 | — | 17 Feb 2024 | |
| Allostery Investments LP |
13F
|
Company |
0.95%
|
479,100
|
$4,057,977 | — | 31 Dec 2024 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.74%
|
375,000
|
$3,176,250 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.74%
|
374,631
|
$3,173,124 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.72%
|
366,170
|
$3,101,460 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.65%
|
327,673
|
$2,775,390 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.65%
|
327,296
|
$2,772,198 | — | 31 Dec 2024 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
0.62%
|
315,700
|
$2,673,979 | — | 31 Dec 2024 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
0.6%
|
303,864
|
$2,573,728 | — | 31 Dec 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.59%
|
300,000
|
$2,541,000 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.57%
|
289,515
|
$2,452,197 | — | 31 Dec 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.53%
|
267,743
|
$2,267,783 | — | 31 Dec 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.34%
|
172,693
|
$1,462,710 | — | 31 Dec 2024 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.31%
|
154,522
|
$1,308,801 | — | 31 Dec 2024 | |
| Edward P. Feener |
3/4/5
|
CHIEF SCIENTIFIC OFFICER |
—
mixed-class rows
|
102,024
mixed-class rows
|
$1,200,262 | — | 17 May 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.27%
|
136,493
|
$1,156,095 | — | 31 Dec 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.26%
|
133,572
|
$1,131,359 | — | 31 Dec 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.25%
|
126,132
|
$1,068,338 | — | 31 Dec 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.24%
|
122,863
|
$1,040,650 | — | 31 Dec 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.23%
|
117,978
|
$999,274 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.22%
|
110,050
|
$932,124 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.2%
|
100,348
|
$849,948 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.19%
|
98,547
|
$834,692 | — | 31 Dec 2024 | |
| Zimmer Partners, LP |
13F
|
Company |
0.19%
|
95,704
|
$810,613 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
0.16%
|
82,005
|
$694,583 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.16%
|
80,443
|
$681,352 | — | 31 Dec 2024 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.16%
|
80,319
|
$680,302 | — | 31 Dec 2024 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.15%
|
74,827
|
$633,785 | — | 31 Dec 2024 |
Institutional Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q1 2025
As of 31 Mar 2025,
KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) was held by
127 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,890,685 shares.
The largest 10 holders included
VR ADVISER, LLC, TANG CAPITAL MANAGEMENT LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, Frazier Life Sciences Management, L.P., Vestal Point Capital, LP, Capital World Investors, BlackRock, Inc., VANGUARD GROUP INC, SILVERARC CAPITAL MANAGEMENT, LLC, and Woodline Partners LP.
This page lists
127
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
129
Q1 2025 holders
127
Holder diff
-2
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.